The Impact of Treatment with Guselkumab on Skin-related Quality of Life in Male and Female Patients with Moderate to Severe Psoriasis: Results from the VOYAGE 1 and 2 Trials

被引：0
|
作者：
Armstrong, April [1 ]
Puig, Luis [2 ]
Papp, Kim A. [3 ]
Strauss, Marcie E. [4 ]
Yang, Ya-Wen [5 ]
Cheng, Ru-Fong [6 ]
Miller, Megan [7 ]
Murase, Jenny E. [8 ,9 ]
Fernandez-Penas, Pablo [10 ]
Han, Chenglong [11 ]
机构：
[1] Univ Southern Calif, Keck Sch Med, Los Angeles, CA USA
[2] Autonomous Univ Barcelona, Hosp Santa Creu & Sant Pau, Barcelona, Spain
[3] K Papp Clin Res & Prob Res Inc, Waterloo, ON, Canada
[4] MEDASOURCE, Indianapolis, IN USA
[5] Janssen Pharmaceut Co Johnson & Johnson, Immunol Global Med Affairs, Horsham, PA USA
[6] Johnson & Johnson, Womens Hlth, Chief Med Off, New Brunswick, NJ USA
[7] Janssen Res & Dev LLC, Spring House, PA USA
[8] Univ Calif San Francisco, San Francisco, CA USA
[9] Palo Alto Fdn Med Grp, Mountain View, CA USA
[10] Westmead Hosp, Sydney Med Sch, Dept Dermatol, Westmead, NSW, Australia
[11] Janssen Global Serv LLC, Malvern, PA USA
来源：
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY | 2023年 / 89卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：AB235 / AB235
页数：1
相关论文
共 50 条
  • [21] CONSISTENCY OF RESPONSE BY WEIGHT ACROSS SUBGROUPS OF PATIENTS WITH PSORIASIS TREATED WITH GUSELKUMAB: RESULTS FROM THE VOYAGE 1 AND 2 TRIALS
    Papp, Kim
    Crowley, Jeffrey
    Rubel, Diana
    Landells, Ian
    Song, Michael
    Wasfi, Yasmine
    You, Yin
    Shen, Yaung-Kaung
    Thaci, Diamant
    ACTA DERMATO-VENEREOLOGICA, 2018, 98 : 20 - 20
  • [22] COMPARING EFFICACY OF GUSELKUMAB VERSUS USTEKINUMAB IN MODERATE TO SEVERE PSORIASIS PATIENTS : AN ADJUSTED COMPARISON BASED ON VOYAGE 1&2 AND NAVIGATE TRIALS
    Diels, J.
    Thilakarathne, P.
    Schubert, A.
    McElligott, S.
    VALUE IN HEALTH, 2017, 20 (09) : A544 - A545
  • [23] Safety in moderate-to-severe plaque psoriasis patients with latent tuberculosis treated with guselkumab and anti-tuberculosis treatments concomitantly: results from pooled phase 3 VOYAGE 1 & VOYAGE 2 trials
    Puig, L.
    Tsai, T. -F.
    Bhutani, T.
    Uy, J.
    Ramachandran, P.
    Song, M.
    You, Y.
    Gooderham, M.
    Lebwohl, M.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2020, 34 (08) : 1744 - 1749
  • [24] LONG-TERM EFFICACY OF GUSELKUMAB TREATMENT AFTER DRUG WITHDRAWAL AND RETREATMENT IN PATIENTS WITH MODERATE-SEVERE PLAQUE PSORIASIS: RESULTS FROM VOYAGE 2
    Gordon, Kenneth
    Armstrong, April
    Foley, Peter
    Wasfi, Yasmine
    Song, Michael
    Shen, Yaung-Kaung
    Li, Shu
    Munoz-Elias, Ernesto J.
    Randazzo, Bruce
    Reich, Kristian
    ACTA DERMATO-VENEREOLOGICA, 2018, 98 : 22 - 23
  • [25] Efficacy responses across subgroups of patients with moderate to severe plaque psoriasis treated with Guselkumab: Results from VOYAGE 1 through 5 years
    Thaci, D.
    Foley, P.
    Puig, L.
    Merola, J. F.
    Miller, M.
    You, Y.
    Shen, Y. -K.
    Yang, Y. -W.
    Blauvelt, A.
    EXPERIMENTAL DERMATOLOGY, 2021, 30 : 41 - 42
  • [26] Malignancy rates through 5 years of follow-up in guselkumab-treated patients with moderate to severe psoriasis: Results from the VOYAGE 1 and 2 trials and comparisons to general populations
    Blauvelt, Andrew
    Langley, Richard G.
    Ho, Vincent
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2022, 87 (03) : AB79 - AB79
  • [27] Impact of ixekizumab on facial psoriasis and related quality of life measures in moderate-to-severe psoriasis patients: 12-week results from two phase III trials
    Paul, C.
    Guenther, L.
    Torii, H.
    Sofen, H.
    Burge, R.
    Lin, C. Y.
    Bleakman, A. Potts
    Mallbris, L.
    Poulin, Y.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2018, 32 (01) : 68 - 72
  • [28] Efficacy of guselkumab in subpopulations of patients with moderate-to-severe plaque psoriasis: a pooled analysis of the phase III VOYAGE 1 and VOYAGE 2 studies
    Gordon, K. B.
    Blauvelt, A.
    Foley, P.
    Song, M.
    Wasfi, Y.
    Randazzo, B.
    Shen, Y. K.
    You, Y.
    Griffiths, C. E. M.
    BRITISH JOURNAL OF DERMATOLOGY, 2018, 178 (01) : 132 - 139
  • [29] Safety of guselkumab in patients with moderate-to-severe psoriasis treated through 100 weeks: a pooled analysis from the randomized VOYAGE 1 and VOYAGE 2 studies
    Reich, K.
    Papp, K. A.
    Armstrong, A. W.
    Wasfi, Y.
    Li, S.
    Shen, Y. K.
    Randazzo, B.
    Song, M.
    Kimball, A. B.
    BRITISH JOURNAL OF DERMATOLOGY, 2019, 180 (05) : 1039 - 1049
  • [30] Impact of guselkumab on quality of life and work productivity outcomes among patients with moderate-to severe plaque psoriasis in the Corrona Psoriasis Registry
    Armstrong, April W.
    Callis-Duffin, Kristina
    Fitzgerald, Timothy
    Teeple, Amanda
    Uy, Jonathan
    Olurinde, Mobolaji
    Rowland, Katelyn
    McLean, Robert R.
    Guo, Lin
    Shan, Ying
    Van Voorhees, Abby S.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2021, 85 (03) : AB66 - AB66
12345